ADMA Biologics
ADMA
#3676
Rank
A$5.25 B
Marketcap
A$22.02
Share price
2.57%
Change (1 day)
-13.45%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: A$5.25 Billion

As of March 2026 ADMA Biologics has a market cap of A$5.25 Billion. This makes ADMA Biologics the world's 3676th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$5.25 B-23.49%
2025A$6.86 B3.57%
2024A$6.63 B342.37%
2023A$1.49 B19.03%
2022A$1.25 B230.72%
2021A$0.38 B58.83%
2020A$0.23 B-29.25%
2019A$0.33 B115.51%
2018A$0.15 B-15.61%
2017A$0.18 B103.56%
2016A$91.53 M-22.87%
2015A$0.11 B-6.42%
2014A$0.12 B56.08%
2013A$81.25 M

End of Day market cap according to different sources

On Mar 1st, 2026 the market cap of ADMA Biologics was reported to be:

A$5.24 Billion
by Nasdaq info icon info icon
A$5.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
A$10.25 B 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$2.33 B-55.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$50.66 M-99.04%๐Ÿ‡บ๐Ÿ‡ธ USA